Status:
COMPLETED
Cold Spray for Pain and Ecchymosis After Anticoagulant Prophylaxis in Orthopedic Surgery
Lead Sponsor:
Kocaeli University
Conditions:
Nursing Care
Cold Application
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Heparin is a widely used anticoagulant for thrombosis prevention, and low molecular weight heparin (LMWH) has become the preferred option due to its higher bioavailability, strong antithrombotic effec...
Detailed Description
Heparin is an anticoagulant used in the surgical prevention of thrombosis and can prevent and treat venous thrombosis by rapidly achieving its anticoagulant effects. Low molecular weight heparin (LMWH...
Eligibility Criteria
Inclusion
- Patients who are:
- 18 years of age or older
- Receiving 1 x 0.4 ml anticoagulant therapy
- Are on the first day of LMWH therapy
- Have no infection, scar tissue, lipodystrophy, or incision at the injection site
- Have not received any other parenteral therapy at the injection site
- Are not allergic to cold or heparin
- Volunteer to participate in the study
Exclusion
- Patients were excluded from the study if they were: • Pregnant, • Had any acute or chronic coagulation disorder or hematological disease,
- Had a subcutaneous injection into the same area 24 hours prior,
- Wanted to withdraw from the study.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT07195955
Start Date
February 1 2024
End Date
February 1 2025
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University
Köseköy, Kocaeli, Turkey (Türkiye), 41100